Remove Chronic Disease Remove Clinic Remove Manufacturing Remove Medical
article thumbnail

Researchers Propose Solutions to Improve GLP-1 RA Access

Physician's Weekly

Cost-sharing and education may improve access to GLP-1 therapies for obesity, but systemic barriers remain, requiring broader policy and clinical reforms. The patient was enrolled in a cost-sharing program that reduced her out-of-pocket expenses by 70%, allowing her to access the medication.

article thumbnail

The MAHA Assessment’s Implications: Drugs (Part One)

FDA Law

The Strategy must address appropriately restructuring the Federal Governments response to the childhood chronic disease crisis, including by ending Federal practices that exacerbate the health crisis or unsuccessfully attempt to address it, and by adding powerful new solutions that will end childhood chronic disease.

article thumbnail

‘MAHA Report’ Calls for Fighting Chronic Disease, but Trump and Kennedy Have Yanked Funding

Physician's Weekly

The Trump administration has declared that it will aggressively combat chronic disease in America. Yet in its feverish purge of federal health programs, it has proposed eliminating the National Center for Chronic Disease Prevention and Health Promotion and its annual funding of $1.4